|
1
|
Liu S, Semenciw R, Ugnat AM and Mao Y:
Increasing thyroid cancer incidence in Canada, 1970–1996: Time
trends and age-period-cohort effects. Br J Cancer. 85:1335–1339.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Parkin DM and Steliarova-Foucher
E: Estimates of cancer incidence and mortality in Europe in 2008.
Eur J Cancer. 46:765–781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Davies L and Welch HG: Current thyroid
cancer trends in the United States. JAMA Otolaryngol Head Neck
Surg. 140:317–322. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aschebrook-Kilfoy B, Schechter RB, Shih
YC, Kaplan EL, Chiu BC, Angelos P and Grogan RH: The clinical and
economic burden of a sustained increase in thyroid cancer
incidence. Cancer Epidemiol Biomarkers Prev. 22:1252–1259. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Behrens J and Lustig B: The Wnt connection
to tumorigenesis. Int J Dev Biol. 48:477–487. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sastre-Perona A and Santisteban P: Role of
the wnt pathway in thyroid cancer. Front Endocrinol (Lausanne).
3:312012.PubMed/NCBI
|
|
7
|
Xing Y, Clements WK, Kimelman D and Xu W:
Crystal structure of a beta-catenin/axin complex suggests a
mechanism for the beta-catenin destruction complex. Genes Dev.
17:2753–2764. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
James RG, Conrad WH and Moon RT:
Beta-catenin-independent Wnt pathways: Signals, core proteins, and
effectors. Methods Mol Biol. 468:131–144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Polakis P: The many ways of Wnt in cancer.
Curr Opin Genet Dev. 17:45–51. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roberts DM, Slep KC and Peifer M: It takes
more than two to tango: Dishevelled polymerization and Wnt
signaling. Nat Struct Mol Biol. 14:463–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katoh M: WNT and FGF gene clusters
(Review). Int J Oncol. 21:1269–1273. 2002.PubMed/NCBI
|
|
12
|
Bohring A, Stamm T, Spaich C, Haase C,
Spree K, Hehr U, Hoffmann M, Ledig S, Sel S, Wieacker P, et al:
WNT10A mutations are a frequent cause of a broad spectrum of
ectodermal dysplasias with sex-biased manifestation pattern in
heterozygotes. Am J Hum Genet. 85:97–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cluzeau C, Hadj-Rabia S, Jambou M, Mansour
S, Guigue P, Masmoudi S, Bal E, Chassaing N, Vincent MC, Viot G, et
al: Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for
90% of hypohidrotic/anhidrotic ectodermal dysplasia cases. Hum
Mutat. 32:70–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nawaz S, Klar J, Wajid M, Aslam M, Tariq
M, Schuster J, Baig SM and Dahl N: WNT10A missense mutation
associated with a complete odonto-onycho-dermal dysplasia syndrome.
Eur J Hum Genet. 17:1600–1605. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen H, Wang Y and Xue F: Expression and
the clinical significance of Wnt10a and Wnt10b in endometrial
cancer are associated with the Wnt/β-catenin pathway. Oncol Rep.
29:507–514. 2013.PubMed/NCBI
|
|
16
|
Hsu RJ, Ho JY, Cha TL, Yu DS, Wu CL, Huang
WP, Chu P, Chen YH, Chen JT and Yu CP: WNT10A plays an oncogenic
role in renal cell carcinoma by activating WNT/β-catenin pathway.
PLoS One. 7:e476492012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kirikoshi H, Inoue S, Sekihara H and Katoh
M: Expression of WNT10A in human cancer. Int J Oncol. 19:997–1001.
2001.PubMed/NCBI
|
|
18
|
Long A, Giroux V, Whelan KA, Hamilton KE,
Tétreault MP, Tanaka K, Lee JS, Klein-Szanto AJ, Nakagawa H and
Rustgi AK: WNT10A promotes an invasive and self-renewing phenotype
in esophageal squamous cell carcinoma. Carcinogenesis. 36:598–606.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Feng C, Xu Z, Li Z, Zhang D, Liu Q and Lu
L: Down-regulation of Wnt10a by RNA interference inhibits
proliferation and promotes apoptosis in mouse embryonic palatal
mesenchymal cells through Wnt/β-catenin signaling pathway. J
Physiol Biochem. 69:855–863. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saiselet M, Floor S, Tarabichi M, Dom G,
Hébrant A, van Staveren WC and Maenhaut C: Thyroid cancer cell
lines: An overview. Front Endocrinol (Lausanne).
3:1332012.PubMed/NCBI
|
|
21
|
van Engeland M, Nieland LJ, Ramaekers FC,
Schutte B and Reutelingsperger CP: Annexin V-affinity assay: A
review on an apoptosis detection system based on phosphatidylserine
exposure. Cytometry. 31:1–9. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barker N, Ridgway RA, van Es JH, van de
Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR,
Sansom OJ and Clevers H: Crypt stem cells as the cells-of-origin of
intestinal cancer. Nature. 457:608–611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Holland JD, Klaus A, Garratt AN and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr
Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Teissedre B, Pinderhughes A, Incassati A,
Hatsell SJ, Hiremath M and Cowin P: MMTV-Wnt1 and
-DeltaN89beta-catenin induce canonical signaling in distinct
progenitors and differentially activate Hedgehog signaling within
mammary tumors. PLoS One. 4:e45372009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vaillant F, Asselin-Labat ML, Shackleton
M, Forrest NC, Lindeman GJ and Visvader JE: The mammary progenitor
marker CD61/beta3 integrin identifies cancer stem cells in mouse
models of mammary tumorigenesis. Cancer Res. 68:7711–7717. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shackleton M, Vaillant F, Simpson KJ,
Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ and
Visvader JE: Generation of a functional mammary gland from a single
stem cell. Nature. 439:84–88. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morgan RG, Ridsdale J, Tonks A and Darley
RL: Factors affecting the nuclear localization of β-catenin in
normal and malignant tissue. J Cell Biochem. 115:1351–1361. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao Z, Herman JG, Brock MV, Sheng J,
Zhang M, Liu B and Guo M: Methylation of DACT2 promotes papillary
thyroid cancer metastasis by activating Wnt signaling. PLoS One.
9:e1123362014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vu-Phan D, Grachtchouk V, Yu J, Colby LA,
Wicha MS and Koenig RJ: The thyroid cancer PAX8-PPARG fusion
protein activates Wnt/TCF-responsive cells that have a transformed
phenotype. Endocr Relat Cancer. 20:725–739. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cho SW, Kim YA, Sun HJ, Ahn HY, Lee EK, Yi
KH, Oh BC, Park DJ, Cho BY and Park YJ: Therapeutic potential of
Dickkopf-1 in wild-type BRAF papillary thyroid cancer via
regulation of β-catenin/E-cadherin signaling. J Clin Endocrinol
Metab. 99:E1641–E1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao H, Li J, Li X, Han C, Zhang Y, Zheng
L and Guo M: Silencing GPX3 expression promotes tumor metastasis in
human thyroid cancer. Curr Protein Pept Sci. 16:316–321. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Deng X, Wu B, Xiao K, Kang J, Xie J, Zhang
X and Fan Y: MiR-146b-5p promotes metastasis and induces
epithelial-mesenchymal transition in thyroid cancer by targeting
ZNRF3. Cell Physiol Biochem. 35:71–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi D, Ramu S, Park E, Jung E, Yang S,
Jung W, Choi I, Lee S, Kim KE, Seong YJ, et al: Aberrant activation
of Notch signaling inhibits PROX1 activity to enhance the malignant
behavior of thyroid cancer cells. Cancer Res. 76:582–593. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gilbert-Sirieix M, Makoukji J, Kimura S,
Talbot M, Caillou B, Massaad C and Massaad-Massade L: Wnt/β-catenin
signaling pathway is a direct enhancer of thyroid transcription
factor-1 in human papillary thyroid carcinoma cells. PLoS One.
6:e222802011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Oda K, Yatera K, Izumi H, Ishimoto H,
Yamada S, Nakao H, Hanaka T, Ogoshi T, Noguchi S and Mukae H:
Profibrotic role of WNT10A via TGF-β signaling in idiopathic
pulmonary fibrosis. Respir Res. 17:392016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kantaputra P, Kaewgahya M and Kantaputra
W: WNT10A mutations also associated with agenesis of the maxillary
permanent canines, a separate entity. Am J Med Genet A.
164A:360–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mostowska A, Biedziak B, Zadurska M,
Matuszewska-Trojan S and Jagodziński PP: WNT10A coding variants and
maxillary lateral incisor agenesis with associated dental
anomalies. Eur J Oral Sci. 123:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zeng B, Xiao X, Li S, Lu H, Lu J, Zhu L,
Yu D and Zhao W: Eight mutations of three genes (EDA, EDAR, and
WNT10A) identified in seven hypohidrotic ectodermal dysplasia
patients. Genes (Basel). 7:72016.
|
|
41
|
Cuellar-Partida G, Springelkamp H, Lucas
SE, Yazar S, Hewitt AW, Iglesias AI, Montgomery GW, Martin NG,
Pennell CE, van Leeuwen EM, et al: WNT10A exonic variant increases
the risk of keratoconus by decreasing corneal thickness. Hum Mol
Genet. 24:5060–5068. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Reddy S, Andl T, Bagasra A, Lu MM, Epstein
DJ, Morrisey EE and Millar SE: Characterization of Wnt gene
expression in developing and postnatal hair follicles and
identification of Wnt5a as a target of Sonic hedgehog in hair
follicle morphogenesis. Mech Dev. 107:69–82. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ji H, Goode RJ, Vaillant F, Mathivanan S,
Kapp EA, Mathias RA, Lindeman GJ, Visvader JE and Simpson RJ:
Proteomic profiling of secretome and adherent plasma membranes from
distinct mammary epithelial cell subpopulations. Proteomics.
11:4029–4039. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kirikoshi H, Sekihara H and Katoh M:
Up-regulation of WNT10A by tumor necrosis factor alpha and
Helicobacter pylori in gastric cancer. Int J Oncol.
19:533–536. 2001.PubMed/NCBI
|
|
45
|
Kirikoshi H, Sekihara H and Katoh M:
WNT10A and WNT6, clustered in human chromosome 2q35 region with
head-to-tail manner, are strongly coexpressed in SW480 cells.
Biochem Biophys Res Commun. 283:798–805. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang J, Gill AJ, Issacs JD, Atmore B,
Johns A, Delbridge LW, Lai R and McMullen TP: The Wnt/β-catenin
pathway drives increased cyclin D1 levels in lymph node metastasis
in papillary thyroid cancer. Hum Pathol. 43:1044–1050. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Glinka A, Wu W, Delius H, Monaghan AP,
Blumenstock C and Niehrs C: Dickkopf-1 is a member of a new family
of secreted proteins and functions in head induction. Nature.
391:357–362. 1998. View
Article : Google Scholar : PubMed/NCBI
|
